Board & Management

Panacor's board & management team is a collection of experienced pharmaceutical executives and proven entrepreneurs with extensive experience in new drug development and business management. Team members possess expertise in the areas of development & regulatory, marketing & licensing, and finance & legal, which are of the cornerstone of our success.

 
 
 

Michael Chiang, Chairman
Mr. Chiang has been Chief Executive Officer of Panion & BF Biotech (Taiwan) for the past 30 years, having formerly been with Bristol Meyer Scripp Inc, Johnson & Johnson and Janssen Pharmaceutical. He has in excess of 30 years¡¦ experience in marketing and sales of pharmaceutical and consumer products.

Winston Town PhD, Chief Executive Officer
Dr. Town is former Senior Vice President of GloboAsia LLC, which provides scientific assistance to applicants seeking regulatory approval for drug development. He has spearheaded seven successful investigational new drug filings with the US Food and Drug Administration and has been consulted on more than ten drug development processes. Dr. Town has an extensive network within Asia and Greater China in sales and marketing. Prior to joining GloboAsia LLC he was with ConAgra International of the US and Hofflinghouse UK, where he was responsible for the development of the marketing and distribution network.

Keith Chan PhD, Chief Scientific Officer
Dr. Chan has extensive drug development experience in industry, regulatory and academic areas. He was formerly the co-founder of GloboMax LLC, Head of Clinical Pharmacokinetics and Research Support at Ciba-Geigy and former Divisional Director of the Office of Generic Drug Products at the US Food and Drug Administration. Dr. Chan holds several academic appointments at the University of Minnesota, the University of Maryland, and as visiting professor at National Cheng-Chi University (Taiwan) and National Yang-Ming University (Taiwan).

David Hsieh, Board member
David is one of the founder of Panion & BF Biotech (Taiwan) and Chairman of SunTen Phytotech (STPT) and board member of Sun Ten Pharmaceutical. He was also chairman of Chinese Pharmaceutical Manufacture and Development Association from 2003 to 2008. With more than 40 years of sales and marketing experience in the pharmaceutical industry, he was also formerly with Pharmacia Upjohn which is now Pfizer.

James Lin, Board member
James Lin has served on the board of Panion & BF Biotech (Taiwan) since it was established in 1976 and is currently the Chairman of Panion & BF Biotech (Taiwan). Upon graduating from the Pharmacy School of Taipei Medical University, Mr. Lin joined as sales representative at Bristol Meyer Scripp Inc. and has served as Chief Pharmacist in Chun-Shan Hospital and Chun-Hwa Hospital in Taiwan in Taiwan. With more than 30 years of leading, monitoring and company diversification in the pharmaceutical industry, Mr. Lin will serve as an executive director on the Board.

Hung-Chih Liu, Board member
Liu has served on the board of Panion & BF Biotech (Taiwan) since its incorporation in 1976. Liu graduated from Pharmacy School of Taipei Medical University and has established a medical device distribution company J.O. Corporation. He was also former director of Taipei Pharmacists¡¦ Association.

Fung-Yao Lue CPA, Board member
Mr. Lu graduated from the Department of Accounting of National Taiwan University and obtained his master degree in Finance from the Texas A&M University of the US. He was former chief executive officer of TSIC Corporation and former vice president of Capital Securities Corporation of Taiwan. Mr. Lu has extensive experience in the financial field; he is currently the chairman of Forbes Financial Services Co.

Wen-Hsien Cheng, Board member
Mr. Cheng is the executive president of Hunan Want Want Hospital and has served on the board of Want Want Holdings since year 2004. Prior to join Want Want Group, Mr. Cheng received his MBA degree in Waseda University of Japan, and served on the top management of several world-renowned financial companies such as Daiwa Securities SMBC-Cathay Co., Ltd.

Shih-Cheng Chuang CPA, Board member
Mr. Chuang has more than twenty years of experience in the accounting and financial management field. Mr. Chuang is currently the chief executive officer of Kuang Tai Financial Services Co. and he is a member of board of directors of several publicly quoted companies. He holds a master degree from the Accounting Department of National Chengchi University (Taiwan).